It has been reported that proanthocyanidin administration significantly inhibits cell proliferation and induces apoptosis in oral squamous cell carcinoma, skin cancer, and colon cancer cells by attenuating the PI3K pathway and decreasing phosphorylated Protein Kinase B (PKB) ser(473) levels (80, 81). The gene discussed is AKT1; the disease is skin cancer.